Navigation Links
Cardica Announces Publication of Case Report in the Journal of Neurosurgery Featuring Use of C-Port(R) System in Brain Arterial Bypass
Date:11/10/2008

- Dr. Ralph G. Dacey, Jr., Successfully Uses C-Port System to Bypass

Cerebral Aneurysm in Patient with Brain Injury -

REDWOOD CITY, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC) today announced publication of a case study in the September issue of the peer-reviewed Journal of Neurosurgery featuring the use of Cardica's C-Port xA(R) Distal Anastomosis System to connect blood vessels in the brain to bypass an enlarging aneurysm.

Ralph G. Dacey, Jr., M.D., professor and chairman of neurological surgery at Washington University School of Medicine in St. Louis, and his colleagues performed neurosurgery on a 43-year-old male patient who sustained a subarachnoid hemorrhage after being assaulted and, as a result, experienced an enlarging aneurysm. Using the C-Port system, the neurosurgeons bypassed the aneurysm using a saphenous vein graft extending from the extracranial common carotid artery to the intracranial middle cerebral artery. The C-Port system performed an automated anastomosis by inserting 13 tiny staples into the graft and recipient vessel. The bypass was demonstrated to be patent (open) on intraoperative and postoperative arteriography, and the patient subsequently made a good neurologic recovery.

"By using the C-Port system instead of hand sewing the vessels in the brain, we were able to reliably connect the graft vessel and significantly reduce the length of time that blood flow was cut off from the brain in this patient," said Dr. Dacey. "In appropriate patients, we believe the C-Port system is a useful addition to the arsenal of tools that neurovascular surgeons have to surgically bypass cerebral aneurysms. We are looking forward to using it in other suitable cases." <
'/>"/>

SOURCE Cardica, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Cardica to Present at William Blair Small-Cap Growth Stock Conference
2. Cardica to Host Conference Call at 11:00 a.m. Eastern Time Tomorrow to Provide Positive Update on Pas-Port(R)
3. Cardica to Announce Fiscal 2008 Fourth Quarter and Year End Financial Results on Tuesday, August 5, 2008
4. Cardica Names Frederick Bauer Vice President of Operations
5. Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C-Port(R) Flex-A(R) Anastomosis System in His Practice and to Educate Cardiothoracic Surgeons
6. Cardica, Intuitive Surgical, MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium
7. Cardica to Announce Fiscal 2008 Third Quarter Financial Results on Tuesday, April 29, 2008
8. Cardicas C-Port Anastomosis Systems Facilitate Beating Heart Bypass Surgery in Study
9. Cardicas C-Port Anastomosis Systems for Coronary Artery Bypass Graft Procedures to be Used to Train Cardiothoracic Surgeons at Society of Thoracic Surgeons (STS) University
10. Cardica to Announce Fiscal 2008 Second Quarter Financial Results on Thursday, January 24, 2008
11. Cardica Announces Exercise of Over-Allotment Option

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...ng someone get blamed for something leads to more ... , SUNDAY, Nov. 29 (HealthDay News) -- The bl... even when the target is innocent. , Researcher... else for a problem, even if it,s an unfair accusa...g others, too. , "When we see others protectin...
(Date:11/29/2009)... "The YogaForce A-Line Athle...says Dr. Andrew Weil, M.D., author and physician b...eld of integrative medicine. Go to www.yogaforce...minded on the gift list. , ...ust in time for the holidays, the YogaForce newly ...
(Date:11/28/2009)... , CHICAGO, Nov. 28 Get ready ...tice in the clinical routine when Siemens intr... Assembly and Annual Meeting of the Radiological S... December 3 at McCormick Place (Booth #825, East B... syngo. via , Siemens, new imaging software...
(Date:11/28/2009)...offer tips to help lift spirits, recognize signs o...thDay News) -- For many seniors, the holiday seaso...loved ones, struggle with health issues or worry a...iatrics Society. , To help overcome the seasona...fers the following advice: , Get out and sociali...
(Date:11/27/2009)... Biotech firm Replikins Ltd. toda...N1 virus genomic data. It shows that the lethalit....d. 4.5) during the virus,s current outbreak in th...is week of 2.0 (s.d. 0.1). The H1N1 infectivity co... Boston (PRWEB) November 27, 2009 -- Biot...
Breaking Medicine News(10 mins):Health News:When Accusations Start to Fly, They Multiply 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5
...p compulsive hair pulling breaks new ground in bat... Lafayette, CO (PRWEB) October 28, 2008 -- O... a quarter-sized bald spot just above her daughter...seem strange to adults but Tina felt tremendous de...
...lth Properties, Inc. (NYSE: NHP ) announced today...share dividend on our common stock that will,be pa...n November 14, 2008., In addition, our Board of D...olders of record on December 15,2008., Nationwide...
...mprove forecasts of dust storms in the American So...agers. Scientists announced the finding as a,five-...Logo: http://www.newscom.com/cgi-bin/prnh/2008100... Tucson,scientists evaluated the influence of spac...
...a Center,presents a public talk and Zen archery wo...ekend, Oct 30 and November 1st and 2nd., This 20t...Japan will,appear for the first time in Los Angele...0th, Shibata Sensei will give a talk on "The Way,t...
...s Corp. ( www.harvesttech.com ) announced today th...icalstudy.com , is now “live”. The sit... enrolling in the Company’s clinical trial a...rsquo;s sites. , PLYMOUT...
...elp consumers get,accurate, dependable information... support consumer,engagement and improved quality ...dorsed guidelines for consumer-focused, internet-b...iendly format that can be used to make informed de...
Other Medicine News:Health News:Mysterious Disfiguring Disorder Responsible For Hair Loss in Over 11 Million American Women 2Health News:Mysterious Disfiguring Disorder Responsible For Hair Loss in Over 11 Million American Women 3Health News:NHP Declares Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 2Health News:NHP Declares Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 3Health News:NASA-Enhanced Dust Storm Predictions to Aid Health Community 2Health News:NASA-Enhanced Dust Storm Predictions to Aid Health Community 3Health News:Renowned Kyudo (Zen archery) Master Kanjuro Shibata Sensei to Present in L.A. 2Health News: Harvest Technologies Announces Patient Education Website, www.CLIclinicalstudy.com : Supports first randomized, placebo-controlled clinical trial in the U.S. using autologous adult stem cells to treat patients with end-stage Critical Limb Ischemia 2Health News:NQF Endorses Guidelines for Consumer-Focused Public Reporting 2Health News:NQF Endorses Guidelines for Consumer-Focused Public Reporting 3Health News:NQF Endorses Guidelines for Consumer-Focused Public Reporting 4Health News:NQF Endorses Guidelines for Consumer-Focused Public Reporting 5
(Date:11/26/2009)...frica, Nov. 26 The 2009 Frost &...in the Generic Pharmaceutical Market is presented ... http://www.newscom.com/cgi-bin/prnh/20081117/FSL... following criteria were used to benchmark Cipla M...h strategy and implementation, degree of innovatio...
(Date:11/25/2009)...25 American Scientific R...is pleased to announce that they have opened a reg...n Shanghai, China. ,, ASR has been able to secu...ay for the development and production of current a...and adults to be distributed and sold globally. C...
(Date:11/25/2009)...5 Hologic, Inc. (Hologic...oper, manufacturer and supplier of premium diagnos...s dedicated to serving the healthcare needs of wom...l Society of North America (RSNA) at McCormick Pla...9 to highlight our new SecurView(®) DX multim...
Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4American Scientific Resources Inc. Opens Shanghai Location 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 1Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 2Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 3Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 4Bayer Diabetes Care Launches A1CNow 28R 29 SELFCHECK a New A1C Monitor for At Home Use 47720 1Bayer Diabetes Care Launches A1CNow 28R 29 SELFCHECK a New A1C Monitor for At Home Use 47720 2Bayer Diabetes Care Launches A1CNow 28R 29 SELFCHECK a New A1C Monitor for At Home Use 47720 3Bayer Diabetes Care Launches A1CNow 28R 29 SELFCHECK a New A1C Monitor for At Home Use 47720 4Scientists create metal that pumps liquid uphill 12431 1Scientists create metal that pumps liquid uphill 12431 2Scientists create metal that pumps liquid uphill 12431 3
...ODLANDS, Texas--(BUSINESS WIRE)--Apr 3, 2007 - Rep...nal results of a U.S.,Phase 2 study of Proellex(TM...s of uterine fibroids. This study suggests that,tr...ighly,significant improvement in symptoms associat...erated., Study Details and Results , This 12 week,...
...gs indicate early non-responders unlikely to subse... costs, and may benefit,from earlier change in tre..., 2007 /PRNewswire-FirstCall/,-- New data presente...nia Research (ICOSR) suggest that antipsychotic dr...thought, and,challenge the current schizophrenia t...
Other Medicine Technology:Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 2Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 3Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 5New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 2New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 3New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 4New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 5New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 6
11968R Standard Reading Test
PowerLab 4/25T
Near PT Test Card/Tumbling E
Illiterate 20' Test Chart
Medicine Products: